Pharma News

Pharma Courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • (Business Wire India); Kiran Mazumdar-Shaw, Chairperson of Asia's premier biopharmaceutical enterprise Biocon Ltd., has been honoured by Federation University Australia (Fed Uni) by dedicating a road at the University’s Mt Helen Campus to her as ‘Mazumdar Drive’. She has also been appointed as an Ambassador of the University for a three-year term.

    [adsense:336x280:8701650588]

  • Toxic mushrooms may hold secrets to tackling deadly diseases such as cancer, according to a new research. A team of Michigan State University scientists has discovered an enzyme that is the key to the lethal potency of poisonous mushrooms.

  • Researchers have identified a network of genes that appear to work together in determining alcohol dependence. By comparing patterns of genetic code from the brain tissue of alcoholics and nonalcoholics, researchers discovered a particular set of genes co-expressed together in the individuals who had consumed the most alcohol.

  • Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) got approval from EU for the prevention of pneumonia caused by the 13 pneumococcal serotypes in the vaccine in adults aged 18 years and older.

  • Human ancestors began evolving the ability to digest alcohol about 10 million years ago, researchers say. The study found that a single genetic mutation 10 million years ago endowed human ancestors with an enhanced ability to break down ethanol.

  • GlaxoSmithKline plc (GSK) announces that its three-part transaction with Novartis has completed today. As a result of this transaction, GSK has acquired Novartis’s global Vaccines business (excluding influenza vaccines) for an initial cash consideration of $5.25 billion; has created a new world-leading Consumer Healthcare joint venture with Novartis in which GSK will have majority control and an equity interest of 63.5%; and has divested its Oncology business for an aggregate cash consideration of $16 billion.

  • Vitamin D supplements can reduce chronic obstructive pulmonary disease (COPD) flare-ups by over 40 per cent in patients with a vitamin D deficiency, according to a new research. Researchers from Queen Mary University of London conducted a randomised trial on 240 patients with COPD in and around London. Half of the patients (122) received vitamin D supplements and the other half (118) received an equivalent placebo.

  • The rapid evolution of HIV, which has allowed the virus to develop resistance to patients' immunity, is at the same time slowing the virus's ability to cause AIDS, according to a new research. The study also suggested that people infected by HIV are likely to progress to AIDS more slowly because of widespread access to antiretroviral therapy (ART).

    [adsense:336x280:8701650588]

Subscribe to Pharma News